Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 13.
Article
Campanilho-Marques, R;
Almeida, B;
Deakin, C;
Arnold, K;
Gallot, N;
de Iorio, M;
Nistala, K;
... Juvenile Dermatomyositis Research Group, .; + view all
(2016)
Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.
Arthritis Care & Research
, 68
(10)
pp. 1514-1521.
10.1002/acr.22867.
|
Campanilho-Marques, R;
Deakin, CT;
Simou, S;
Papadopoulou, C;
Wedderburn, LR;
Pilkington, CA;
Juvenile Dermatomyositis Research Group (JDRG);
(2020)
Retrospective analysis of infliximab and
adalimumab treatment in a large cohort of
juvenile dermatomyositis patients.
Arthritis Research & Therapy
, 22
(1)
, Article 79. 10.1186/s13075-020-02164-5.
|
Deakin, CT;
Campanilho-Marques, R;
Simou, S;
Moraitis, E;
Wedderburn, LR;
Pullenayegum, E;
Pilkington, CA;
(2018)
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Arthritis & Rheumatology
, 70
(5)
pp. 785-793.
10.1002/art.40418.
|
Deakin, CT;
Yasin, SA;
Simou, S;
Arnold, KA;
Tansley, SL;
Betteridge, ZE;
McHugh, NJ;
... UK Juvenile Dermatomyositis Research Group, .; + view all
(2016)
Muscle biopsy in combination with myositis-specific autoantibodies aids prediction of outcomes in juvenile dermatomyositis.
Arthritis & Rheumatology
, 68
(11)
pp. 2806-2816.
10.1002/art.39753.
|
Piper, CJM;
Wilkinson, MGL;
Deakin, CT;
Otto, GW;
Dowle, S;
Duurland, CL;
Adams, S;
... Marques, R; + view all
(2018)
CD19+CD24hiCD38hi B Cells Are Expanded in Juvenile Dermatomyositis and Exhibit a Pro-Inflammatory Phenotype After Activation Through Toll-Like Receptor 7 and Interferon-α.
Frontiers in Immunology
, 9
, Article 1372. 10.3389/fimmu.2018.01372.
|
Rothwell, S;
Chinoy, H;
Lamb, JA;
Miller, FW;
Rider, LG;
Wedderburn, LR;
McHugh, NJ;
... Myositis Genetics Consortium (MYOGEN), .; + view all
(2019)
Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups.
Annals of the Rheumatic Diseases
, 78
pp. 996-1002.
10.1136/annrheumdis-2019-215046.
|
Soponkanaporn, S;
Deakin, CT;
Schutz, PW;
Marshall, LR;
Yasin, SA;
Johnson, CM;
Sag, E;
... Jacques, TS; + view all
(2019)
Expression of myxovirus‐resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Neuropathology and Applied Neurobiology
, 45
(4)
pp. 410-420.
10.1111/nan.12498.
|
van Dijkhuizen, EHP;
De Iorio, M;
Wedderburn, LR;
Deakin, CT;
JDRG;
(2018)
Clinical signs and symptoms in a joint model of four disease activity parameters in juvenile dermatomyositis: a prospective, longitudinal, multicenter cohort study.
Arthritis Research & Therapy
, 20
(1)
, Article 180. 10.1186/s13075-018-1687-8.
|
van Dijkhuizen, EP;
Deakin, CT;
Wedderburn, LR;
De Iorio, M;
(2017)
Modelling disease activity in juvenile dermatomyositis: A Bayesian approach.
Statistical Methods in Medical Research
10.1177/0962280217713233.
(In press).
|
Wedderburn, LR;
Webb, K;
Peckham, H;
Radziszewska, A;
Menon, M;
Oliveri, P;
Simpson, F;
... Ioannou, Y; + view all
(2019)
Sex and Pubertal Differences in the Type 1 Interferon Pathway Associate With Both X Chromosome Number and Serum Sex Hormone Concentration.
Frontiers in Immunology
, 9
, Article 3167. 10.3389/fimmu.2018.03167.
|
Wienke, J;
Bellutti Enders, F;
Lim, J;
Mertens, JS;
van den Hoogen, LL;
Wijngaarde, CA;
Yeo, JG;
... van Wijk, F; + view all
(2019)
Galectin-9 and CXCL10 as biomarkers for disease activity in juvenile dermatomyositis: a longitudinal cohort study and multi-cohort validation.
Arthritis and Rheumatology
, 71
(8)
pp. 1377-1390.
10.1002/art.40881.
|
Wienke, J;
Deakin, CT;
Wedderburn, LR;
van Wijk, F;
van Royen-Kerkhof, A;
(2018)
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools.
Frontiers in Immunology
, 9
, Article 2951. 10.3389/fimmu.2018.02951.
|
Yasin, SA;
Schutz, PW;
Deakin, CT;
Sag, E;
Varsani, H;
Simou, S;
Marshall, LR;
... UK Juvenile Dermatomyositis Research Group (UK-Ireland); + view all
(2019)
Histological heterogeneity in a large clinical cohort of juvenile idiopathic inflammatory myopathy: analysis by myositis autoantibody and pathological features.
Neuropathology and Applied Neurobiology
, 45
(5)
pp. 495-512.
10.1111/nan.12528.
|